Arya Vaidya Sala

Malappuram, India Founded: 1902 • Age: 124 yrs Listed
Offers classical Ayurvedic medicines and authentic treatments to patients worldwide.
Request Access
Report Incorrect Data
Page last updated

About Arya Vaidya Sala

Arya Vaidya Sala is a publicly listed company based in Malappuram (India) founded in 1902. It offers classical Ayurvedic medicines and authentic treatments to patients worldwide. It operates on a B2C and D2C model. The company has 16 employees. Its website aryavaidyasala.com draws about 340 thousand monthly visits. Its Indian entity Inspirisys Solutions Limited reported revenue of ₹489 Cr. Arya Vaidya Sala offers products and services including Ayurvedic Medicines, Consultation Services, and In-Patient Treatments. Its focus areas include Health and Wellness, Alternative Medicine, Ayurveda and Treatments and Products. Its competitors include AyurVAID Hospitals, Kerala Ayurveda and AVN Arogya; 1 of its 3 listed competitors has raised funding.

Company details

Arya Vaidya Sala is a charitable institution based in Kottakkal, Kerala, India, focused on practicing and propagating Ayurveda. It delivers classical Ayurvedic medicines, therapies, and consultations to patients from India and abroad through hospitals, clinics, and online platforms. The organization manufactures over 500 formulations and provides in-patient, walk-in, and video consultations while selling products via dealers and e-commerce.

Operational Areas
Healthcare → Alternative Medicine Products
Key Metrics
  • Market Cap
    ₹381 Cr

    INSPIRISYS · NSE

  • Share Price
    ₹96.01

    -0.17% today

  • Revenue
    ₹476 Cr

    FY 2025-26 · +22.6% YoY

  • EBITDA
    ₹36.72 Cr

    Margin 7.7%

  • Net Profit
    ₹42.56 Cr

    FY 2025-26 · +39.3% YoY

  • P/E (TTM)
    9.2x

    P/B 3.7x

  • ROE
    24.2%

    ROCE 17.4%

  • Debt / Equity
    1.05

    Interest cover 24.7x

  • Employee Count
    16

Products & Services of Arya Vaidya Sala

Arya Vaidya Sala offers a comprehensive portfolio of products and services, including Ayurvedic Medicines, Consultation Services, and In-Patient Treatments.

Ayurvedic Medicines
Herbal Products

Classical formulations for health and wellness treatments.

Consultation Services
Health Services

Online and in-person Ayurvedic health advice for patients.

In-Patient Treatments
Therapy Services

Hospital-based Ayurvedic therapies for intensive care.

Apps and channels of Arya Vaidya Sala

Arya Vaidya Sala publishes 2 mobile apps with over 100K+ downloads; its YouTube channel Arya Vaidya Sala Kottakkal has 17.9K subscribers and 30 videos.

Kottakkal Ayurveda
Google Play Health & Fitness Everyone Free
Developer: Arya Vaidya Sala Kottakkal
View on Google Play
Kottakkal Ayurveda
App Store Health & Fitness 17+
Developer: ARYA VAIDYA SALA
View on App Store
Arya Vaidya Sala Kottakkal
YouTube 17.9K subscribers 30 videos Howto & Style
Open channel

Videos from Arya Vaidya Sala

The most watched videos on Arya Vaidya Sala's YouTube channel, Arya Vaidya Sala Kottakkal (17.9K subscribers). Click a video to play it here.

Two is better than one! Kottakkal's Anti-Dandruff and Hair Nourishing Oil + Shampoo
217.5K views
Kottakkal C-Health Forte | Kottakkal Arya Vaidya Sala | Authentic Ayurveda
10.9K views
Manasamitravatakam I Medicine I Kottakkal Arya Vaidya Sala
7.2K views
World Sexual Health Day I Arya Vaidya Sala, Kottakkal
5.1K views

More on Arya Vaidya Sala Kottakkal.

Board of directors of Inspirisys Solutions Limited (Arya Vaidya Sala)

Inspirisys Solutions Limited is the primary company behind Arya Vaidya Sala. The board of Inspirisys Solutions Limited currently have 6 directors; the longest-serving is Rajesh Muni, appointed in 2017. 24 earlier directors have ceased.

DirectorDesignationAppointedTenureEntity
Rajesh Muni
DIN 00193527
Director06 May 20179 yrs 6 moInspirisys Solutions Limited
Murari Jagan
DIN 02002827
Director07 Feb 20206 yrs 9 moInspirisys Solutions Limited
Gopalakrishnan Murali
DIN 08066529
Whole-time director01 Nov 20224 yrsInspirisys Solutions Limited
Toru Horiuchi
DIN 08111162
Director01 Nov 20224 yrsInspirisys Solutions Limited
Dharmaraj Cauvery
DIN 02917088
Director08 Aug 20242 yrs 2 moInspirisys Solutions Limited
Satoshi Iwanaga
DIN 10817792
Director01 Jan 20251 yr 10 moInspirisys Solutions Limited

IPO & Listings of Arya Vaidya Sala

Arya Vaidya Sala is a publicly listed company on the NSE with ticker symbol INSPIRISYS in India, operating in the IT - Software sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.

  • Listed onNSE: INSPIRISYS
  • Listed entityInspirisys Solutions Limited
  • Exchange sectorIT - Software

Financials of Arya Vaidya Sala

Exchange-reported figures of Inspirisys Solutions Limited, the listed company behind Arya Vaidya Sala (NSE: INSPIRISYS).

Financial Highlights

FY 2025-26 · Consolidated
Revenue
₹476 Cr
+22.6% YoY
EBITDA
₹36.72 Cr
+32.0% YoY
Profit After Tax
₹42.56 Cr
+39.3% YoY
Net Worth
₹100 Cr
+71.2% YoY
Total Assets
₹187 Cr
+30.2% YoY
Total Debt
₹82.47 Cr
-2.4% YoY

Revenue vs Net Profit ₹ Cr

Margin trends

Financial summary ₹ Cr

MetricsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Income statement
Revenue476388490372342404458
Revenue growth+22.6%-20.9%+32.0%+8.8%-15.4%-12.0%-
EBITDA36.7227.8120.0310.05(3.07)11.3017.71
EBITDA margin+7.7%+7.2%+4.1%+2.7%-0.9%+2.8%+3.9%
Profit before tax36.8628.408.631.57(11.63)(0.94)5.53
Net profit42.5630.5616.3616.35(13.34)(2.86)2.41
Net profit margin+8.9%+7.9%+3.3%+4.4%-3.9%-0.7%+0.5%
EPS (₹)10.348.010.92(0.64)(3.37)(0.72)0.61
Balance sheet
Total assets187144113106118122167
Net worth10058.5329.29(8.37)0.7915.2817.64
Total debt82.4784.5083.0110510998.56142
Cash & bank13.3134.7459.0832.0321.8330.8215.38
Net working capital33.1648.9454.4948.1052.8649.8766.05
Cash flow
Cash from operations22.8638.7028.7718.19(11.90)71.9542.38
Cash from investing(33.12)(45.93)(12.61)1.632.91(3.58)(2.43)
Cash from financing(7.16)(15.03)0.97(10.84)0.00(52.93)(36.37)
ParticularsJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue10714213012084.6012079.5184.15
Revenue growth (YoY)+26.4%+17.8%+63.3%+42.3%-18.8%---
Other income2.745.373.672.202.0510.411.122.16
EBITDA6.4610.964.9912.218.5611.354.725.77
EBITDA margin+6.0%+7.7%+3.8%+10.2%+10.1%+9.4%+5.9%+6.9%
Depreciation1.451.441.401.261.312.710.910.70
Interest1.843.241.701.531.271.732.092.53
Profit before tax5.9111.655.5611.628.0317.322.844.70
Tax1.842.88(13.06)4.221.895.06(10.36)0.93
Net profit4.078.7718.627.406.1412.2613.203.77
EPS (₹)1.032.214.711.871.543.103.340.95
MetricsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Income statement
Revenue466378478355298326345
Revenue growth+23.2%-20.8%+34.5%+19.0%-8.6%-5.5%-
EBITDA32.1724.3234.9629.347.8112.2521.06
EBITDA margin+6.9%+6.4%+7.3%+8.3%+2.6%+3.8%+6.1%
Profit before tax34.1422.7526.5722.062.002.409.69
Net profit39.7925.0021.6017.950.290.486.57
Net profit margin+8.5%+6.6%+4.5%+5.1%+0.1%+0.2%+1.9%
EPS (₹)9.666.585.454.530.070.121.66
Balance sheet
Total assets184143157141138157190
Net worth17513711189.9572.1072.0472.33
Total debt4.705.1145.1844.7959.3578.37112
Cash & bank11.8332.8456.9630.3016.7526.9712.22
Net working capital29.7447.9398.5985.3473.2283.7786.93
Cash flow
Cash from operations20.1175.9936.3635.9513.0058.4247.38
Cash from investing(32.48)(45.85)(12.45)1.062.85(3.57)(2.74)
Cash from financing(4.60)(51.97)(7.40)(24.68)(26.07)(40.10)(38.62)
ParticularsJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue10413912811782.1711877.3381.74
Revenue growth (YoY)+26.9%+18.1%+64.9%+43.6%-19.1%---
Other income2.734.491.702.221.884.921.981.56
Total expenses98.7813012310674.7910873.3277.28
EBITDA5.469.554.0611.187.3810.274.014.46
EBITDA margin+5.2%+6.9%+3.2%+9.5%+9.0%+8.7%+5.2%+5.5%
Depreciation1.441.431.411.251.312.720.900.70
Interest0.630.361.050.880.631.091.311.70
Profit before tax6.1212.253.3011.277.3211.383.783.62
Tax1.842.89(13.07)4.211.905.06(10.35)0.92

Financial Statements

Figures in ₹ Cr; negatives in brackets. Updated 07 Nov 2026
ParticularsJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue10714213012084.6012079.5184.15
Revenue growth (YoY)+26.4%+17.8%+63.3%+42.3%-18.8%---
Other income2.745.373.672.202.0510.411.122.16
EBITDA6.4610.964.9912.218.5611.354.725.77
EBITDA margin+6.0%+7.7%+3.8%+10.2%+10.1%+9.4%+5.9%+6.9%
Depreciation1.451.441.401.261.312.710.910.70
Interest1.843.241.701.531.271.732.092.53
Profit before tax5.9111.655.5611.628.0317.322.844.70
Tax1.842.88(13.06)4.221.895.06(10.36)0.93
Net profit4.078.7718.627.406.1412.2613.203.77
EPS (₹)1.032.214.711.871.543.103.340.95
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Revenue476388490372342404458
Revenue growth+22.6%-20.9%+32.0%+8.8%-15.4%-12.0%-
Other income13.2914.743.734.875.365.429.77
Total expenses439360470362345392441
Employee cost126120123114125125126
EBITDA36.7227.8120.0310.05(3.07)11.3017.71
EBITDA margin+7.7%+7.2%+4.1%+2.7%-0.9%+2.8%+3.9%
Depreciation5.415.394.585.575.496.937.81
Interest7.748.7610.557.788.4310.7314.14
Profit before tax36.8628.408.631.57(11.63)(0.94)5.53
Tax(4.12)(3.33)4.974.111.711.923.12
Net profit42.5630.5616.3616.35(13.34)(2.86)2.41
Net profit margin+8.9%+7.9%+3.3%+4.4%-3.9%-0.7%+0.5%
EPS (₹)10.348.010.92(0.64)(3.37)(0.72)0.61
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Equity & liabilities
Share capital39.6239.6239.6239.6239.6239.6239.62
Reserves & surplus60.5918.91(10.33)(47.99)(38.83)(24.34)(21.98)
Shareholders' funds (net worth)10058.5329.29(8.37)0.7915.2817.64
Minority interest0.000.000.000.000.000.000.00
Secured loans0.340.440.610.420.450.6412.84
Unsecured loans82.1384.0682.4010510997.92129
Total debt82.4784.5083.0110510998.56142
Total liabilities187144113106118122167
Assets
Gross block52.0552.7648.6965.8163.7858.8459.14
Net block9.6811.0213.6415.5918.4616.8322.31
Capital work in progress0.001.930.810.420.004.262.35
Investments86.8243.780.000.000.000.000.00
Inventories9.129.3811.1011.4512.2513.0414.11
Sundry debtors13884.7898.1883.4864.7194.71133
Cash & bank balances13.3134.7459.0832.0321.8330.8215.38
Loans & advances51.1249.5843.1335.1043.3343.6147.80
Total current assets212178211162142182210
Total current liabilities17813015711489.26132144
Net working capital33.1648.9454.4948.1052.8649.8766.05
Total assets187144113106118122167
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Opening cash25.6847.9430.8121.8330.8215.3811.80
Net cash from operating activities22.8638.7028.7718.19(11.90)71.9542.38
Net cash from investing activities(33.12)(45.93)(12.61)1.632.91(3.58)(2.43)
Net cash from financing activities(7.16)(15.03)0.97(10.84)0.00(52.93)(36.37)
Net change in cash(17.42)(22.26)17.138.98(8.99)15.443.58
Closing cash13.3134.7459.0832.0321.8330.8215.38
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Growth
Sales growth+22.6%-20.9%+32.0%+8.8%-15.4%-12.0%-
EBITDA growth+32.0%+38.8%+99.3%+427.4%-127.2%-36.2%-
PBT growth+29.8%+229.1%+449.7%+9998.0%-1137.2%-+36.5%
Net income growth+39.3%+86.8%+0.1%+222.6%-366.4%-218.7%-
Revenue CAGR (3Y)+8.6%+4.4%+6.7%-6.8%-14.5%-5.9%-8.0%
EBITDA CAGR (3Y)+54.0%-+21.0%-17.2%---13.0%
Profitability & leverage
Net income margin+8.6%+8.2%+0.8%-0.7%-3.9%-0.7%+0.5%
Return on capital employed+17.5%+12.7%+18.5%0.0%0.0%0.0%+6.3%
Return on net worth+24.2%+19.9%+22.4%0.0%0.0%0.0%+1.6%
Debt / equity1.051.918.990.0012.927.3053.06
Long-term debt / equity1.021.010.590.000.742.1419.20
Interest cover24.7239.0768.28173.66-98.48245.54142.83
Efficiency & per share
Fixed asset turnover9.087.658.575.745.576.848.64
Inventory turnover51.4537.9143.5031.3627.0229.7429.21
Debtors turnover4.274.245.405.024.293.552.71
EPS (₹)10.348.010.92(0.64)(3.37)(0.72)0.61
Dividend per share (₹)0.000.000.000.000.000.000.00
Book value per share (₹)25.2914.777.39(2.11)0.203.864.45
ParticularsJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue10413912811782.1711877.3381.74
Revenue growth (YoY)+26.9%+18.1%+64.9%+43.6%-19.1%---
Other income2.734.491.702.221.884.921.981.56
Total expenses98.7813012310674.7910873.3277.28
EBITDA5.469.554.0611.187.3810.274.014.46
EBITDA margin+5.2%+6.9%+3.2%+9.5%+9.0%+8.7%+5.2%+5.5%
Depreciation1.441.431.411.251.312.720.900.70
Interest0.630.361.050.880.631.091.311.70
Profit before tax6.1212.253.3011.277.3211.383.783.62
Tax1.842.89(13.07)4.211.905.06(10.35)0.92
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Revenue466378478355298326345
Revenue growth+23.2%-20.8%+34.5%+19.0%-8.6%-5.5%-
Other income10.299.513.674.805.164.628.83
Total expenses434354443326291314324
Employee cost11911210999.0593.3989.2784.81
EBITDA32.1724.3234.9629.347.8112.2521.06
EBITDA margin+6.9%+6.4%+7.3%+8.3%+2.6%+3.8%+6.1%
Depreciation5.405.394.585.585.476.697.64
Interest2.925.697.486.505.507.7812.56
Profit before tax34.1422.7526.5722.062.002.409.69
Tax(4.12)(3.33)4.974.111.711.923.12
Net profit39.7925.0021.6017.950.290.486.57
Net profit margin+8.5%+6.6%+4.5%+5.1%+0.1%+0.2%+1.9%
EPS (₹)9.666.585.454.530.070.121.66
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Equity & liabilities
Share capital39.6239.6239.6239.6239.6239.6239.62
Reserves & surplus13597.2671.4950.3332.4832.4232.71
Shareholders' funds (net worth)17513711189.9572.1072.0472.33
Secured loans0.340.440.610.420.450.640.80
Unsecured loans4.364.6744.5744.3758.9077.73111
Total debt4.705.1145.1844.7959.3578.37112
Total liabilities184143157141138157190
Assets
Gross block52.0450.3648.6948.9546.9242.0042.84
Net block9.6410.9913.5615.5118.3616.7221.07
Capital work in progress0.001.930.810.420.004.262.35
Investments86.8243.780.000.000.001.204.93
Inventories9.129.3711.1011.4512.2513.0411.30
Sundry debtors13583.2313611889.70110122
Cash & bank balances11.8332.8456.9630.3016.7526.9712.22
Loans & advances50.0248.6141.7127.3635.3735.2038.40
Total current assets206174246187154185184
Total current liabilities17612614710180.8510196.93
Net working capital29.7447.9398.5985.3473.2283.7786.93
Total assets184143157141138157190
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Opening cash23.7645.5929.0816.7526.9712.226.20
Net cash from operating activities20.1175.9936.3635.9513.0058.4247.38
Net cash from investing activities(32.48)(45.85)(12.45)1.062.85(3.57)(2.74)
Net cash from financing activities(4.60)(51.97)(7.40)(24.68)(26.07)(40.10)(38.62)
Net change in cash(16.97)(21.83)16.5112.33(10.22)14.756.02
Closing cash11.8332.8456.9630.3016.7526.9712.22
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Growth
Sales growth+23.2%-20.8%+34.5%+19.0%-8.6%-5.5%-
EBITDA growth+32.3%-30.4%+19.2%+275.7%-36.2%-41.8%-
PBT growth+50.1%-14.4%+20.4%+1003.0%-16.7%-75.2%+87.1%
Net income growth+59.2%+15.7%+20.3%+6089.7%-39.6%-92.7%-
Revenue CAGR (3Y)+9.5%+8.2%+13.6%+1.0%-12.4%-6.5%-1.7%
EBITDA CAGR (3Y)+3.1%+46.0%+41.8%+11.7%-24.4%-6.0%+30.2%
Profitability & leverage
Net income margin+8.2%+6.9%+4.5%+5.1%+0.1%+0.2%+1.9%
Return on capital employed+21.2%+15.2%+16.2%+13.0%+3.2%+3.9%+7.8%
Return on net worth+22.8%+16.2%+13.4%+11.1%+0.2%+0.3%+4.5%
Debt / equity0.030.200.450.640.961.322.48
Long-term debt / equity0.020.010.010.020.050.390.87
Interest cover10.9130.0624.6227.36235.04139.9393.59
Efficiency & per share
Fixed asset turnover9.117.649.797.416.717.699.31
Inventory turnover50.4336.9742.3829.9823.6026.8126.58
Debtors turnover4.273.453.773.433.002.822.44
EPS (₹)9.666.585.454.530.070.121.66
Dividend per share (₹)0.000.000.000.000.000.000.00
Book value per share (₹)44.0534.5528.0422.7018.2018.1818.26

Competitors of Arya Vaidya Sala

Arya Vaidya Sala has 3 listed competitors in our database, 1 of them funded. They include AyurVAID Hospitals, Kerala Ayurveda and AVN Arogya.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
AyurVAID Hospitals
ayurvaid.com2005Bengaluru, India$2.78M157
A chain of Ayurveda hospitals is operated in India.
Kerala Ayurveda
keralaayurveda.biz1945Kochi, India350
Chain of complementary and alternative therapy hospitals
AVN Arogya
avnarogya.in1930Madurai, India646
Offers Ayurvedic healthcare services for treatments and preventive medicine.
Premium access

Detailed competitors of Arya Vaidya Sala

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Web traffic of Arya Vaidya Sala

The website of Arya Vaidya Sala (aryavaidyasala.com) receives about 339.5K visits a month and ranks #115,508 among all websites worldwide, #3,412 in Health.

  • Monthly visits
    339.5K

    ▼ 5.6% vs previous month

  • Unique visitors
    180.9K

    per month

  • Global rank
    #115,508

    among all websites

  • Category rank
    #3,412

    Health · Health

Similar websites

Websites whose visitors overlap most with Arya Vaidya Sala. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
Vedi Herbals
vediherbals.com
100%
44.3K#673,440View details
trichurheart.com
trichurheart.com
98%
–
Dr. Vaidya’s
drvaidyas.com
96%
292.3K#213,781View details
Tata 1mg
1mg.com
90%
44.9M#1,062View details
Ayush Arogyam
ayusharogyam.com
89%
17.1K#1,523,747View details
••••••••••••••••.com••%•.•M#•••••–
••••••••••••••••.com••%•.•M#•••••–
••••••••••••••••.com••%•.•M#•••••–
Premium access

All 40 similar websites and full traffic analytics for Arya Vaidya Sala

The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.

  • 40 similar websites
  • Audience overlap
  • Engagement analytics
  • Traffic by brand

Verified entity values are shown only after access is granted.

Top companies in Alternative Medicine Products

3 companies that operate in the same segment as Arya Vaidya Sala (Alternative Medicine Products) in India, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Schwabe India
Homeopathic medicine manufacturing and online retail in India.
1898Noida, Uttar Pradesh, IndiaUSD 26.35 M1,192
Healthmug
Operates an online store specializing in ayurvedic and homeopathic medicines.
2016Delhi, Delhi, IndiaUSD 1.25 M16
Jiva Ayurveda
Offers Ayurvedic treatments, consultations, and products for various diseases and wellness.
1992Faridabad, Haryana, IndiaUSD 10.08 M570
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • ✓
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • ✓
    Full access to every database India & global coverage, advanced filters and rich profile details
  • ✓
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Arya Vaidya Sala

Inspirisys Solutions & CAC Holdings Bring OCTOps into the Limelight
Inspirisys • 1 month ago
Inspirisys Solutions Ltd June-Quarter Consol Net Profit From Continuing Operations 40.7 Million Rupees
Reuters • 2 months ago
Inspirisys Solutions Says Tax Demands Of 10.9 Million Rupees Dismissed By Appellate Tribunal
Reuters • 2 months ago
Inspirisys Solutions Resolves Litigation With Kerala Medical Services Corporation
Reuters • 5 months ago
Inspirisys Solutions Dec-Quarter Consol Net Profit 166.6 Million Rupees
Reuters • 9 months ago
Inspirisys Solutions Tax Demand Of 50.3 Million Rupees Dropped
Reuters • 10 months ago
Inspirisys Solutions consolidated net profit rises 146.59% in the June 2025 quarter | Capital Market News - Business Standard
Business Standard • 1 year ago
Inspirisys Solutions Ltd leads gainers in 'B' group | Capital Market News - Business Standard
Business Standard • 1 year ago
Inspirisys Solutions consolidated net profit rises 227.81% in the March 2025 quarter | Capital Market News - Business Standard
Business Standard • 1 year ago
Inspirisys Solu Consolidated December 2024 Net Sales at Rs 79.51 crore, down 34.6% Y-o-Y
Moneycontrol • 1 year ago
Premium access

Complete news archive for Arya Vaidya Sala

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Arya Vaidya Sala

Arya Vaidya Sala was founded in 1902.

Arya Vaidya Sala is headquartered in Malappuram, India. It is registered at Malappuram, Kerala, India.

Arya Vaidya Sala has 16 employees.

The primary company behind Arya Vaidya Sala, Inspirisys Solutions Limited, reported revenue of ₹489 Cr for FY 2026, up 23% year on year.

Arya Vaidya Sala is a charitable institution based in Kottakkal, Kerala, India, focused on practicing and propagating Ayurveda. It delivers classical Ayurvedic medicines, therapies, and consultations to patients from India and abroad through hospitals, clinics, and online platforms. The organization manufactures over 500 formulations and provides in-patient, walk-in, and video consultations while selling products via dealers and e-commerce.

Arya Vaidya Sala's top competitors include AyurVAID Hospitals, Kerala Ayurveda and AVN Arogya.

Arya Vaidya Sala offers Ayurvedic Medicines, Consultation Services, and In-Patient Treatments.

Yes, Arya Vaidya Sala is publicly traded on NSE under the ticker symbol INSPIRISYS.

Arya Vaidya Sala operates through Inspirisys Solutions Limited.

The legal entities of Arya Vaidya Sala currently have 8 directors, including Rajesh Muni, Murari Jagan, Shanmugam Sundaramurthy and others.

Yes. Arya Vaidya Sala publishes Kottakkal Ayurveda and 1 more app, with over 100,000 downloads.

The website of Arya Vaidya Sala receives about 340 thousand visits a month and ranks #115,508 among all websites worldwide.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available